Transdermal Synthetic CBD

Trials studying Transdermal Synthetic CBD

• phase2Study of Cannabidiol and Neuroimaging on Stressrecruitingn=160
• phase4Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solutionactive not recruitingn=154
• phase3Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factorsterminatedn=90
• phase2Unique Treatment of Oncology Pain in Advanced Cancercompletedn=11
• phase2Safety and Effect on Pain and Function According to RAPID-3 of IHL-675A in Patients With Rheumatoid Arthritisterminatedn=20
• phase4A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complexactive not recruitingn=79
• phase3Stratification and Treatment in Early Psychosis Study - PROMOTEnot yet recruitingn=586
• phase1Safety and Pharmacokinetics of Cannabidiol in Healthy Volunteerscompletedn=20